How Long Does 1 Shot of Ozempic Last? Your Guide to Dosing

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

A single semaglutide injection enters your bloodstream and remains active for roughly seven days, making weekly dosing the standard protocol for weight management. Understanding how long each dose lasts helps you maintain consistent appetite suppression and metabolic benefits between injections. PlexusDx provides personalized semaglutide therapy with dosing schedules tailored to your body's response.

How Long Does One Semaglutide Injection Actually Last

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist designed to remain in your system for approximately seven days after injection. The medication reaches peak concentration within one to three days, then gradually decreases over the following week. By day seven, most patients notice appetite suppression beginning to fade, which is why weekly injections maintain steady therapeutic levels rather than daily dosing.

Clinical studies tracking semaglutide's pharmacokinetics show a half-life of approximately seven days, meaning roughly 50 percent of the drug remains in your body after one week. This extended duration allows for convenient once-weekly administration while maintaining consistent GLP-1 receptor activation in appetite-control centers of the brain. The predictable timeline helps patients plan meals and snacks with confidence, knowing their medication's strength remains relatively stable throughout the week.

Understanding Semaglutide Dosing Schedules and Escalation

Most semaglutide treatment plans begin at lower doses and increase gradually over weeks or months to minimize side effects and optimize weight loss. A typical schedule might start at 0.25 milligrams weekly for four weeks, then advance based on tolerability and hunger reduction. Your dose may increase multiple times during the first few months, but PlexusDx keeps your monthly cost flat—your dose may go up, your price won't.

The PlexusDx Precision Peptide Genetic Test analyzes MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Why Weekly Injections Are More Effective Than Other Schedules

Weekly semaglutide dosing aligns with the medication's natural metabolism and provides superior appetite suppression compared to less frequent schedules. Injecting once per week maintains steady-state drug levels that prevent the hunger rebound some patients experience if doses are spaced further apart. This consistency delivers reliable satiety signals, reduced cravings, and sustained metabolic acceleration week after week.

Daily or twice-weekly dosing schedules would require much lower per-injection amounts and create unnecessary complexity for patients managing their weight loss journey. The once-weekly format represents an ideal balance between sustained therapeutic benefit and practical convenience for real-world adherence. Research shows patients who maintain consistent weekly timing experience better long-term weight loss outcomes than those with irregular injection patterns.

Personalizing Your Semaglutide Timeline With PlexusDx

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Licensed 503A compounding pharmacies prepare PlexusDx semaglutide injections with pharmaceutical-grade quality, available across all 50 states without insurance requirements. Treatment is $189/mo month-to-month, or from $149/mo on the 6-month plan flat, with HSA and FSA eligibility reducing out-of-pocket expenses. Adding the Precision Peptide Genetic Test ($298) unlocks personalized guidance on 14 metabolic pathways and 150+ genetic insights specific to your weight loss potential.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What happens if I miss my weekly semaglutide injection?

Missing one injection delays your next dose window slightly, but your previous injection remains somewhat active through day seven. If you miss by one or two days, take your next dose as scheduled and resume your regular weekly rhythm. Missing multiple doses reduces continuous appetite suppression and may slow your weight loss progress, so setting phone reminders helps maintain consistency.

Can semaglutide dose last longer than one week?

While semaglutide's half-life is approximately seven days, individual metabolism varies due to body composition, kidney function, and genetic factors. Some patients report sustained appetite reduction into day eight or nine, while others notice effects declining by day six. PlexusDx personalizes your injection schedule based on your response pattern rather than assuming standard seven-day timing for everyone.

Why is semaglutide from PlexusDx more affordable than brand-name Ozempic?

PlexusDx partners with licensed 503A compounding pharmacies to prepare pharmaceutical-grade semaglutide at a fraction of brand-name costs. Compounded semaglutide begins at $189 monthly flat-rate pricing, includes all dose escalations without price increases, and requires no insurance or membership fees. HSA and FSA accounts further reduce your monthly investment in consistent weight loss therapy.

Are there side effects that develop as semaglutide wears off mid-week?

Some patients report mild hunger increases by day six or seven as medication levels decline naturally before their next injection. This is normal and doesn't indicate treatment failure—it simply reflects the medication's pharmacokinetic timeline. Staying hydrated, eating protein-rich meals, and planning snacks strategically helps bridge the pre-injection period without derailing your weight loss.

How does my genetic makeup affect how long semaglutide works for me?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.